RANDALL COBB: Open Payments
NPI 1750314605 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 74 payments from 12 companies in 2025. Trend: 2023 $1,901 · 2024 $1,112 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $193 |
| Janssen Pharmaceuticals, Inc | 8 | $150 |
| Teva Pharmaceuticals USA, Inc. | 12 | $142 |
| Otsuka America Pharmaceutical, Inc. | 7 | $119 |
| Vanda Pharmaceuticals Inc. | 4 | $99 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| Lundbeck LLC | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: ARISTADA, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, AUSTEDO XR, FANAPT, Auvelity, UZEDY.
Industry payments across FL — which companies pay providers there.
